Zobrazeno 1 - 10
of 78
pro vyhledávání: '"Emanuela Bartoccioni"'
Autor:
Mariapaola Marino, Umberto Basile, Gregorio Spagni, Cecilia Napodano, Raffaele Iorio, Francesca Gulli, Laura Todi, Carlo Provenzano, Emanuela Bartoccioni, Amelia Evoli
Publikováno v:
Frontiers in Immunology, Vol 11 (2020)
The use of rituximab (RTX), an anti-CD20 monoclonal antibody (Ab), in refractory myasthenia gravis (MG) is associated with a better response in patients with Abs to the muscle-specific tyrosine kinase (MuSK) than in other MG subgroups. Anti-MuSK Abs
Externí odkaz:
https://doaj.org/article/0ad1969741b245079a5905aa99cc99ec
Autor:
Umberto Basile, Mariapaola Marino, Cecilia Napodano, Krizia Pocino, Paolo Emilio Alboini, Francesca Gulli, Amelia Evoli, Carlo Provenzano, Emanuela Bartoccioni
Publikováno v:
Journal of Immunology Research, Vol 2018 (2018)
Background. Serological levels of free immunoglobulin light chains (FLCs), produced in excess of heavy chains during synthesis of immunoglobulins by plasma cells, can be considered a direct marker of B cell activity in different systemic inflammatory
Externí odkaz:
https://doaj.org/article/7800774ef15747ad99d271f430c29ae2
Autor:
Mariapaola Marino, Flavia Scuderi, Daniela Samengo, Giorgia Saltelli, Maria Teresa Maiuri, Chengyong Shen, Lin Mei, Mario Sabatelli, Giovambattista Pani, Giovanni Antonini, Amelia Evoli, Emanuela Bartoccioni
Publikováno v:
PLoS ONE, Vol 10, Iss 8, p e0135378 (2015)
Myasthenia gravis (MG) is an autoimmune disease in which 90% of patients have autoantibodies against the muscle nicotinic acetylcholine receptor (AChR), while autoantibodies to muscle-specific tyrosine kinase (MuSK) have been detected in half (5%) of
Externí odkaz:
https://doaj.org/article/f32e1f61d1d3499f99f91be4a202d12b
Publikováno v:
Mediators of Inflammation, Vol 2015 (2015)
Pertrochanteric fractures are common injuries in adults and source of morbidity and mortality among the elderly. Different surgical techniques were recommended for their treatment but undoubtedly they add an additional inflammatory trauma along the f
Externí odkaz:
https://doaj.org/article/4ea7ef03ebeb442084877a17418a5b33
Autor:
Fabio Coppedè, Roberta Ricciardi, Maria Denaro, Anna De Rosa, Carlo Provenzano, Emanuela Bartoccioni, Angelo Baggiani, Marco Lucchi, Alfredo Mussi, Lucia Migliore
Publikováno v:
PLoS ONE, Vol 8, Iss 11, p e80846 (2013)
Increasing evidence suggests a contribution of epigenetic processes in promoting cancer and autoimmunity. Myasthenia gravis (MG) is an autoimmune disease mediated, in approximately 80% of the patients, by antibodies against the nicotinic acetylcholin
Externí odkaz:
https://doaj.org/article/c74fa9a3f8ff45de97d117f7f3b6b7a5
Publikováno v:
Annals of the New York Academy of Sciences. 1413:41-48
In recent years, rituximab (RTX), a monoclonal antibody that binds the B lymphocyte membrane protein CD20, has been increasingly used for the treatment of autoimmune diseases, with the rationale of destroying pathogenic B lymphocytes and decreasing a
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::2dc9e230c361ff0d12c2a3e80471b106
https://doi.org/10.1111/nyas.13562
https://doi.org/10.1111/nyas.13562
Autor:
Mariapaola Marino, Carlo Provenzano, Raffaele Iorio, Valentina Damato, Amelia Evoli, Paolo Emilio Alboini, Emanuela Bartoccioni
Publikováno v:
Annals of the New York Academy of Sciences. 1412:82-89
Myasthenia gravis with antibodies to the muscle-specific tyrosine kinase (MuSK+ MG) is a rare disease with distinctive pathogenic mechanisms and clinical features. An acute onset and predominant bulbar muscle weakness are very common and highly sugge
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::4c281b6ced71f1f6469028e7b0990624
https://doi.org/10.1111/nyas.13518
https://doi.org/10.1111/nyas.13518
Autor:
Tanel Punga, Emanuela Bartoccioni, Marta K Lewandowska, Valentina Damato, Anna Rostedt Punga, Amelia Evoli
Publikováno v:
Journal of Neuroimmunology. 292:21-26
Myasthenia gravis (MG) patients with antibodies against the muscle specific tyrosine kinase (MuSK+) have predominantly involvement of cranio-bulbar muscles and do not display thymus pathology, as do acetylcholine receptor antibody seropositive (AChR+
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::42442f64e21a819615bf32c76da56d36
Publikováno v:
Journal of Neurology, Neurosurgery & Psychiatry. 88:761-763
Background Myasthenia gravis (MG) with antibodies to the muscle-specific kinase (MuSK) has a characteristic phenotype. Ocular manifestations have not been systematically evaluated. Objective To investigate the features of extrinsic ocular muscle invo
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::30d7618514eefe3f29f49436dc5749ba
https://doi.org/10.1136/jnnp-2017-315782
https://doi.org/10.1136/jnnp-2017-315782
Autor:
Amelia, Evoli, Paolo E, Alboini, Valentina, Damato, Raffaele, Iorio, Carlo, Provenzano, Emanuela, Bartoccioni, Mariapaola, Marino
Myasthenia gravis with antibodies to the muscle-specific tyrosine kinase (MuSK
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=pmid_dedup__::4ef13222b2154837750b27a38b747a54
https://hdl.handle.net/10807/113282
https://hdl.handle.net/10807/113282
